European product
CE marking
MDR certification
Backed by clinical trials
Private label available




VeTCROSS
Intra-articular hyaluronic acid solution.
Formulated using SARE Technology® to ensure improved joint function, durability and comfort.
- Concentration
- 2.0%
- Presentation (format)
- 2 mL prefilled syringe
- Certification
- Veterinary health material and equipment product
- Shelf life
- 2 years
- Technology
- SARE Technology
Degradación Lenta
Elasticidad y resistencia
Visco-Elástico
Buen perfil de seguridad
SARE Technology ®
Advantages
- Manufactured in Europe to demanding quality standards.
- Optimal safety profile.
- Optimal viscosity and elasticity for uniform distribution, improving product adhesion and efficacy.
- Ideal vehicle for administering therapeutic and cosmetic substances.
Indications
Intended to act as a medium for the localised administration of substances to the skin, mucous membranes and other anatomical areas, and to maintain a moist, stable microenvironment that supports the protection, lubrication and hydration of tissues in animals such as dogs, cats and horses.
Properties
High- and low-molecular-weight cross-linked hyaluronic acid obtained through biofermentation and of high purity.
Directions for use
Administer the product evenly over the area of interest, taking into account the anatomical characteristics of the area to be treated. The product must be applied only by veterinary professionals.
Technology
SARE Technology
An innovative hyaluronic acid cross-linking method that delivers unique results through a highly homogeneous cross-linking process.
A proprietary combination of low- and high-molecular-weight hyaluronic acid that creates a polymer matrix with a low degree of modification.
- Manufactured in Europe to demanding quality standards.
- Optimal safety profile.
- Optimal viscosity and elasticity for uniform distribution, improving product adhesion and efficacy.
- Ideal vehicle for administering therapeutic and cosmetic substances.
Productos relacionados

VeTCROSS
Formulated using SARE Technology® to ensure improved joint function, durability and comfort.

VeTVISC 1.4%
Maximum protection of the corneal endothelium and adjacent tissues

VeTVISC 2.0 %
Maintenance of anterior chamber space and protection of the corneal endothelium and adjacent tissues

VeTVISC 3.0 %
Maximum maintenance of anterior chamber space.